» Articles » PMID: 26702435

Selective Targeting of the BRG/PB1 Bromodomains Impairs Embryonic and Trophoblast Stem Cell Maintenance

Abstract

Mammalian SWI/SNF [also called Brg/Brahma-associated factors (BAFs)] are evolutionarily conserved chromatin-remodeling complexes regulating gene transcription programs during development and stem cell differentiation. BAF complexes contain an ATP (adenosine 5'-triphosphate)-driven remodeling enzyme (either BRG1 or BRM) and multiple protein interaction domains including bromodomains, an evolutionary conserved acetyl lysine-dependent protein interaction motif that recruits transcriptional regulators to acetylated chromatin. We report a potent and cell active protein interaction inhibitor, PFI-3, that selectively binds to essential BAF bromodomains. The high specificity of PFI-3 was achieved on the basis of a novel binding mode of a salicylic acid head group that led to the replacement of water molecules typically maintained in other bromodomain inhibitor complexes. We show that exposure of embryonic stem cells to PFI-3 led to deprivation of stemness and deregulated lineage specification. Furthermore, differentiation of trophoblast stem cells in the presence of PFI-3 was markedly enhanced. The data present a key function of BAF bromodomains in stem cell maintenance and differentiation, introducing a novel versatile chemical probe for studies on acetylation-dependent cellular processes controlled by BAF remodeling complexes.

Citing Articles

Epigenetics-targeted drugs: current paradigms and future challenges.

Dai W, Qiao X, Fang Y, Guo R, Bai P, Liu S Signal Transduct Target Ther. 2024; 9(1):332.

PMID: 39592582 PMC: 11627502. DOI: 10.1038/s41392-024-02039-0.


Tumor suppressors RBL1 and PTEN are epigenetically silenced in IPF mesenchymal progenitor cells by a CD44/Brg1/PRMT5 regulatory complex.

Yang L, Xia H, Smith K, Gilbertsen A, Jbeli A, Abrahante J Am J Physiol Lung Cell Mol Physiol. 2024; 327(6):L949-L963.

PMID: 39406384 PMC: 11684952. DOI: 10.1152/ajplung.00182.2024.


Single-molecule imaging of SWI/SNF chromatin remodelers reveals bromodomain-mediated and cancer-mutants-specific landscape of multi-modal DNA-binding dynamics.

Engl W, Kunstar-Thomas A, Chen S, Ng W, Sielaff H, Zhao Z Nat Commun. 2024; 15(1):7646.

PMID: 39223123 PMC: 11369179. DOI: 10.1038/s41467-024-52040-y.


BRG1 promotes progression of B-cell acute lymphoblastic leukemia by disrupting PPP2R1A transcription.

Kang Q, Ma D, Zhao P, Chai X, Huang Y, Gao R Cell Death Dis. 2024; 15(8):621.

PMID: 39187513 PMC: 11347705. DOI: 10.1038/s41419-024-06996-w.


Targeting the chromatin remodelling protein Brahma-related gene 1 for intervention of pulmonary fibrosis.

Wu T, Wang B, Gui X, Liu R, Wei D, Xu Y Clin Transl Med. 2024; 14(8):e1775.

PMID: 39167021 PMC: 11337535. DOI: 10.1002/ctm2.1775.


References
1.
Vidler L, Brown N, Knapp S, Hoelder S . Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites. J Med Chem. 2012; 55(17):7346-59. PMC: 3441041. DOI: 10.1021/jm300346w. View

2.
Nguyen C, Young T, Gilson M . Grid inhomogeneous solvation theory: hydration structure and thermodynamics of the miniature receptor cucurbit[7]uril. J Chem Phys. 2012; 137(4):044101. PMC: 3416872. DOI: 10.1063/1.4733951. View

3.
Owen D, Ornaghi P, Yang J, Lowe N, Evans P, Ballario P . The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p. EMBO J. 2000; 19(22):6141-9. PMC: 305837. DOI: 10.1093/emboj/19.22.6141. View

4.
Jones S, Wang T, Shih I, Mao T, Nakayama K, Roden R . Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science. 2010; 330(6001):228-31. PMC: 3076894. DOI: 10.1126/science.1196333. View

5.
Wang Z, Zhai W, Richardson J, Olson E, Meneses J, Firpo M . Polybromo protein BAF180 functions in mammalian cardiac chamber maturation. Genes Dev. 2004; 18(24):3106-16. PMC: 535920. DOI: 10.1101/gad.1238104. View